Adverse Hair Reactions to New Targeted Therapies for Cancer
March 2019
in “
Actas Dermo-Sifiliográficas
”
alopecia hair color changes hair shape changes hair growth changes EGFR inhibitors BRAF inhibitors MEK inhibitors regorafenib Hedgehog inhibitors vismodegib VEGF inhibitors VEGFR inhibitors sorafenib sunitinib depigmentation hair loss epidermal growth factor receptor inhibitors vascular endothelial growth factor inhibitors
Studysummary This review discusses the adverse effects on hair associated with targeted cancer therapies and reports no new clinical results; it emphasizes the need for comprehensive documentation of these effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →